BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 10069875)

  • 1. Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin.
    Spahn JD; Leung DY; Chan MT; Szefler SJ; Gelfand EW
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):421-6. PubMed ID: 10069875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluticasone propionate results in improved glucocorticoid receptor binding affinity and reduced oral glucocorticoid requirements in severe asthma.
    Nimmagadda SR; Spahn JD; Nelson HS; Jenkins J; Szefler SJ; Leung DY
    Ann Allergy Asthma Immunol; 1998 Jul; 81(1):35-40. PubMed ID: 9690571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired anti-inflammatory action of glucocorticoid in neutrophil from patients with steroid-resistant asthma.
    Wang M; Gao P; Wu X; Chen Y; Feng Y; Yang Q; Xu Y; Zhao J; Xie J
    Respir Res; 2016 Nov; 17(1):153. PubMed ID: 27852250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of glucocorticoids on lymphocyte activation in patients with steroid-sensitive and steroid-resistant asthma.
    Spahn JD; Landwehr LP; Nimmagadda S; Surs W; Leung DY; Szefler SJ
    J Allergy Clin Immunol; 1996 Dec; 98(6 Pt 1):1073-9. PubMed ID: 8977508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clarithromycin potentiates glucocorticoid responsiveness in patients with asthma: results of a pilot study.
    Spahn JD; Fost DA; Covar R; Martin RJ; Brown EE; Szefler SJ; Leung DY
    Ann Allergy Asthma Immunol; 2001 Dec; 87(6):501-5. PubMed ID: 11770698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma.
    Kishiyama JL; Valacer D; Cunningham-Rundles C; Sperber K; Richmond GW; Abramson S; Glovsky M; Stiehm R; Stocks J; Rosenberg L; Shames RS; Corn B; Shearer WT; Bacot B; DiMaio M; Tonetta S; Adelman DC
    Clin Immunol; 1999 May; 91(2):126-33. PubMed ID: 10227804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of glucocorticoids on endogenous and transcellular metabolism of eicosanoids in asthma.
    Vachier I; Chavis C; Majori M; Farce M; Bousquet J; Godard P; Chanez P
    J Allergy Clin Immunol; 2001 May; 107(5):824-31. PubMed ID: 11344349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary estimation of results of high-dose intravenous immunoglobulin in severe steroid-dependent adult asthma].
    Kłos K; Kruszewski J
    Pol Merkur Lekarski; 2001 Nov; 11(65):379-83. PubMed ID: 11852803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of high-dose i.v. immunoglobulin in patients with severe steroid-dependent asthma.
    Landwehr LP; Jeppson JD; Katlan MG; Esterl B; McCormick D; Hamilos DL; Gelfand EW
    Chest; 1998 Nov; 114(5):1349-56. PubMed ID: 9824013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.
    Fish JE; Karpel JP; Craig TJ; Bensch GW; Noonan M; Webb DR; Silverman B; Schenkel EJ; Rooklin AR; Ramsdell JW; Nathan R; Leflein JG; Grossman J; Graft DF; Gower RG; Garay SM; Frigas E; Degraff AC; Bronsky EA; Bernstein DI; Berger W; Shneyer L; Nolop KB; Harrison JE
    J Allergy Clin Immunol; 2000 Nov; 106(5):852-60. PubMed ID: 11080706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear translocation of the glucocorticoid receptor in fibroblasts of asthmatic patients with nasal polyposis insensitive to glucocorticoid treatment.
    Embid C; Fernández-Bertolín L; Pujols L; Alobid I; Mullol J; Picado C
    Arch Bronconeumol; 2011 Mar; 47(3):115-21. PubMed ID: 21288619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro.
    Corrigan CJ; Brown PH; Barnes NC; Szefler SJ; Tsai JJ; Frew AJ; Kay AB
    Am Rev Respir Dis; 1991 Nov; 144(5):1016-25. PubMed ID: 1952426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased glucocorticoid binding affinity to glucocorticoid receptor is important in the poor response to steroid therapy of older-aged patients with severe bronchial asthma.
    Cho YJ; Lee KE
    Allergy Asthma Proc; 2003; 24(5):353-8. PubMed ID: 14619336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergen exposure decreases glucocorticoid receptor binding affinity and steroid responsiveness in atopic asthmatics.
    Nimmagadda SR; Szefler SJ; Spahn JD; Surs W; Leung DY
    Am J Respir Crit Care Med; 1997 Jan; 155(1):87-93. PubMed ID: 9001294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced glucocorticoid binding affinity in asthma is related to ongoing allergic inflammation.
    Spahn JD; Leung DY; Surs W; Harbeck RJ; Nimmagadda S; Szefler SJ
    Am J Respir Crit Care Med; 1995 Jun; 151(6):1709-14. PubMed ID: 7767511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: a double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma. Pulmicort Turbuhaler Study Group.
    Nelson HS; Bernstein IL; Fink J; Edwards TB; Spector SL; Storms WW; Tashkin DP
    Chest; 1998 May; 113(5):1264-71. PubMed ID: 9596304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.
    Nelson HS; Busse WW; deBoisblanc BP; Berger WE; Noonan MJ; Webb DR; Wolford JP; Mahajan PS; Hamedani AG; Shah T; Harding SM
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):267-75. PubMed ID: 9949318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid resistant asthma: T-lymphocyte steroid metabolism and sensitivity to glucocorticoids and immunosuppressive agents.
    Corrigan CJ; Bungre JK; Assoufi B; Cooper AE; Seddon H; Kay AB
    Eur Respir J; 1996 Oct; 9(10):2077-86. PubMed ID: 8902470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome.
    Wakim M; Alazard M; Yajima A; Speights D; Saxon A; Stiehm ER
    Ann Allergy Asthma Immunol; 1998 Aug; 81(2):153-8. PubMed ID: 9723561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of PBMCs to predict clinical response to corticosteroids in asthmatic patients.
    Goleva E; Jackson LP; Gleason M; Leung DY
    J Allergy Clin Immunol; 2012 Mar; 129(3):687-693.e1. PubMed ID: 22236730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.